ALVO
ALVO
NASDAQ · Biotechnology

Alvotech Sa

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$3.72
+0.02 (+0.54%)
As of Jun 24, 1:46 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 9 75%
Hold 2 17%
Sell 1 8%
Price Target
Analyst Price Target +752.7% upside
Low Target $22.31
Average Target $31.72
High Target $46.94
Current Price $3.72
Current
$3.72
Target
$31.72
$22.31 $31.72 avg $46.94
Scenario Analysis
Bear Case
$22.31
499.7%
Low target
Base Case
$31.72
+752.7%
Avg target
Bull Case
$46.94
+1,161.8%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$9.94
-62.6% from high
52-Week Low
$2.94
+26.5% from low
Target vs 52W High
$31.72
+219.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.6%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.9%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +188.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -8.5%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.9%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.0%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.4%